Weekly Intelligence · 3 articles
Vet Industry Intel: Apr 12 – Apr 18, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Regulatory & Policy (2)
Products & Technology (1)
Regulatory & Policy
Apr 15, 2026 [8/10] DVM360
Ready-to-use feline OA stem cell therapy gains entry to FDA’s faster conditional approval pathway
A ready-to-use feline osteoarthritis stem cell therapy has been accepted into the FDA's conditional approval pathway.
FDA · DVM360
Apr 17, 2026 [7/10] AGDAILY
Four animal drugs cleared to fight New World screwworm
The FDA cleared four animal drugs to combat the New World screwworm.
FDA · AGDAILY
Products & Technology
Apr 15, 2026 [7/10] PR Newswire
Gallant Reports Positive Pilot Data for Feline Osteoarthritis Stem Cell Therapy; Receives FDA Eligibility for Expanded Conditional Approval Pathway
Gallant announced positive pilot data for its feline osteoarthritis stem cell therapy and received FDA eligibility for an expanded conditional approval pathway.
Gallant · FDA · PR Newswire